BR112014017630A2 - - Google Patents

Info

Publication number
BR112014017630A2
BR112014017630A2 BR112014017630A BR112014017630A BR112014017630A2 BR 112014017630 A2 BR112014017630 A2 BR 112014017630A2 BR 112014017630 A BR112014017630 A BR 112014017630A BR 112014017630 A BR112014017630 A BR 112014017630A BR 112014017630 A2 BR112014017630 A2 BR 112014017630A2
Authority
BR
Brazil
Application number
BR112014017630A
Other languages
Portuguese (pt)
Other versions
BR112014017630A8 (pt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BR112014017630A2 publication Critical patent/BR112014017630A2/pt
Publication of BR112014017630A8 publication Critical patent/BR112014017630A8/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306Solid-phase reaction mechanisms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
BR112014017630A 2012-02-01 2013-01-29 Métodos para a determinação de presença e/ou da quantidade de um antígeno BR112014017630A8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12153457 2012-02-01
EP12182505 2012-08-31
PCT/EP2013/051604 WO2013113663A1 (en) 2012-02-01 2013-01-29 Method for the detection of a binding partner of a multispecific binder

Publications (2)

Publication Number Publication Date
BR112014017630A2 true BR112014017630A2 (enExample) 2017-06-20
BR112014017630A8 BR112014017630A8 (pt) 2017-07-11

Family

ID=47624068

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014017630A BR112014017630A8 (pt) 2012-02-01 2013-01-29 Métodos para a determinação de presença e/ou da quantidade de um antígeno

Country Status (10)

Country Link
US (3) US9945869B2 (enExample)
EP (1) EP2810074B1 (enExample)
JP (3) JP2015507193A (enExample)
KR (1) KR20140128314A (enExample)
CN (2) CN104105966B (enExample)
BR (1) BR112014017630A8 (enExample)
CA (1) CA2859268A1 (enExample)
MX (1) MX349661B (enExample)
RU (1) RU2620563C2 (enExample)
WO (1) WO2013113663A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140128314A (ko) 2012-02-01 2014-11-05 에프. 호프만-라 로슈 아게 다중특이적 결합제의 결합 파트너 검출 방법
MX346146B (es) 2012-07-13 2017-03-09 Hoffmann La Roche Metodo para detectar un aglutinante multiespecifico.
EP3066469B1 (en) 2013-11-05 2017-10-11 Roche Diagnostics GmbH A method for determining the total amount and/or concentration of an analyte in the presence of a binding molecule as well as kits, compositions and uses relating thereto
CN104109197B (zh) * 2013-11-13 2017-05-10 叶森 一种双识别抗体片段的制备方法及其应用
WO2017055399A1 (en) 2015-10-02 2017-04-06 F. Hoffmann-La Roche Ag Cellular based fret assay for the determination of simultaneous binding
CR20180161A (es) 2015-10-02 2018-05-25 Hoffmann La Roche Anticuerpos biespecíficos para pd1 y tim3
US20220009988A1 (en) * 2017-02-06 2022-01-13 Biotempt B.V. Peptide modulators of the interaction between human c-peptide and human elastin receptor for therapeutic use
LT3606946T (lt) 2017-04-03 2022-10-25 F. Hoffmann-La Roche Ag Anti-pd-1 antikūno imunokonjugatai su mutantiniu il-2 arba su il-15
KR102346336B1 (ko) 2017-04-05 2022-01-04 에프. 호프만-라 로슈 아게 Pd1 및 lag3에 특이적으로 결합하는 이중특이적 항체
JP7370322B2 (ja) 2018-06-04 2023-10-27 中外製薬株式会社 複合体を検出する方法
CN113811770B (zh) * 2019-05-13 2024-06-28 豪夫迈·罗氏有限公司 抑制干扰的药代动力学免疫测定
WO2022065052A1 (ja) * 2020-09-24 2022-03-31 株式会社Jvcケンウッド 捕捉用抗体、固相担体、検出用抗体、固相担体粒子、並びに検出対象物質の測定キット及び測定方法
CN117805397A (zh) * 2024-02-29 2024-04-02 军科正源(北京)药物研究有限责任公司 检测游离vegf的方法

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219730A (en) 1982-09-28 1993-06-15 New York University Idiotype-anti-idiotype immunoassay
US4828981A (en) 1983-08-24 1989-05-09 Synbiotics Corporation Immunoassays for determining Dirofilaria immitis infection using antiidiotype monoclonal antibody reagents
EP0170302A1 (fr) 1984-06-27 1986-02-05 l'Association internationale à but scientifique, dite: Institut international de pathologie cellulaire et moléculaire Procédé de dosage immunologique d'une substance dans un échantillon liquide au moyen d'anticorps anti-idiotypiques
US5238808A (en) 1984-10-31 1993-08-24 Igen, Inc. Luminescent metal chelate labels and means for detection
EP0243471A4 (en) 1985-10-22 1989-07-11 Cooper Lipotech Inc SOLID PHASE LIPOSOME IMMUNOANALYSIS SYSTEM.
US5068088A (en) 1988-11-03 1991-11-26 Igen, Inc. Method and apparatus for conducting electrochemiluminescent measurements
EP0757252A3 (en) 1988-11-03 1997-04-16 Igen Inc Electrochemiluminescent test procedure
IL100866A (en) 1991-02-06 1995-10-31 Igen Inc Method and apparatus for magnetic microparticulate based luminescence assay including plurality of magnets
DK0651761T3 (da) 1992-07-13 2003-02-10 Bionebraska Inc Fremgangsmåde til modifikation af rekombinante polypeptider
JPH097096A (ja) 1995-06-20 1997-01-10 Alpine Electron Inc 緊急車両接近時の報知方法
JPH0975096A (ja) * 1995-09-14 1997-03-25 Snow Brand Milk Prod Co Ltd ラクトフェリンの測定法
AU757691B2 (en) 1997-11-21 2003-03-06 Inverness Medical Switzerland Gmbh Improvements in or relating to displacement assays
JPH11352129A (ja) * 1998-06-04 1999-12-24 Mizuho Medeii:Kk 検出装置及び検出方法
US6753189B1 (en) * 1998-06-04 2004-06-22 Mizuho Medy Co., Ltd. Detection apparatus and method for the same
NZ518363A (en) * 1999-11-16 2003-01-31 Genentech Inc Elisa for vascular endothelial growth factor using monoclonal and polyclonal antibodies
GB0007088D0 (en) * 2000-03-23 2000-05-17 Torsana A S Detection of immunological memory determining the position of loci of pathologyand therapeutic t-cell conjugates
US6984494B2 (en) 2000-08-15 2006-01-10 Genentech, Inc. Analytical method
US7341837B2 (en) 2003-09-02 2008-03-11 Lawton Robert L Soluble analyte detection and amplification
EP1861708A2 (en) 2005-03-08 2007-12-05 Tanox, Inc. Methods for determining the bivalency of protein and antibody therapeutics
US7494776B2 (en) 2005-07-07 2009-02-24 Beckman Coulter, Inc. Labeled complementary oligonucleotides to detect oligonucleotide-linked ligands
ZA200801154B (en) * 2005-07-21 2009-07-29 Genmab As Potency assays for antibody drug substance binding to an FC receptor
NZ589687A (en) 2005-07-21 2012-09-28 Genmab As Potency assays for antibody drug substance binding to an FC receptor
BRPI0715239A2 (pt) * 2006-10-04 2013-06-25 Genentech Inc mÉtodo para detectar formas de fator de crescimento endotelial vascular (vegf) seletivas (vegf110+), kit de imunoensaio, anticorpo 5c3 e hibridoma 5c3.1.1
EP1917854A1 (en) 2006-11-06 2008-05-07 F. Hoffmann-La Roche Ag Method for producing anti idiotypic antibodies
US9266967B2 (en) 2007-12-21 2016-02-23 Hoffmann-La Roche, Inc. Bivalent, bispecific antibodies
US8227577B2 (en) 2007-12-21 2012-07-24 Hoffman-La Roche Inc. Bivalent, bispecific antibodies
US8242247B2 (en) 2007-12-21 2012-08-14 Hoffmann-La Roche Inc. Bivalent, bispecific antibodies
US20090162359A1 (en) 2007-12-21 2009-06-25 Christian Klein Bivalent, bispecific antibodies
NZ589434A (en) * 2008-06-03 2012-11-30 Abbott Lab Dual variable domain immunoglobulins and uses thereof
JP5634405B2 (ja) * 2008-10-07 2014-12-03 ユィロス・パテント・アクチボラグGyros Patent AB 試料中のアナライトの検出のための半逐次アッセイ
AU2010230563A1 (en) 2009-04-02 2011-09-22 Roche Glycart Ag Multispecific antibodies comprising full length antibodies and single chain Fab fragments
SI2417156T1 (sl) 2009-04-07 2015-06-30 Roche Glycart Ag Trivalentna, bispecifiäśna protitelesa
WO2010136172A1 (en) 2009-05-27 2010-12-02 F. Hoffmann-La Roche Ag Tri- or tetraspecific antibodies
US9676845B2 (en) 2009-06-16 2017-06-13 Hoffmann-La Roche, Inc. Bispecific antigen binding proteins
US8703132B2 (en) 2009-06-18 2014-04-22 Hoffmann-La Roche, Inc. Bispecific, tetravalent antigen binding proteins
CN105624118B (zh) * 2009-10-19 2019-08-13 弗·哈夫曼-拉罗切有限公司 非交叉反应性抗IgG抗体
CN102207504A (zh) * 2011-03-23 2011-10-05 北京华创远航科技有限公司 一种酶联检测试剂盒及其制备方法
BR112014011535A2 (pt) 2011-12-19 2017-05-09 Hoffmann La Roche método para a determinação in vitro e imunológica de presença da presença e/ou da quantidade de um parceiro de ligação, método in vitro e utilização de um anticorpo
KR20140128314A (ko) 2012-02-01 2014-11-05 에프. 호프만-라 로슈 아게 다중특이적 결합제의 결합 파트너 검출 방법
WO2013130412A1 (en) * 2012-02-27 2013-09-06 Bio-Rad Laboratories, Inc. Anti-immune complex antibodies
MX346146B (es) 2012-07-13 2017-03-09 Hoffmann La Roche Metodo para detectar un aglutinante multiespecifico.

Also Published As

Publication number Publication date
US9945869B2 (en) 2018-04-17
US20210055304A1 (en) 2021-02-25
BR112014017630A8 (pt) 2017-07-11
CA2859268A1 (en) 2013-08-08
RU2620563C2 (ru) 2017-05-26
JP2019113564A (ja) 2019-07-11
EP2810074A1 (en) 2014-12-10
CN104105966B (zh) 2016-10-26
JP6678792B2 (ja) 2020-04-08
WO2013113663A1 (en) 2013-08-08
JP2015507193A (ja) 2015-03-05
KR20140128314A (ko) 2014-11-05
US20180328942A1 (en) 2018-11-15
HK1202921A1 (en) 2015-10-09
EP2810074B1 (en) 2017-08-23
JP6502441B2 (ja) 2019-04-17
MX349661B (es) 2017-08-08
US10761097B2 (en) 2020-09-01
MX2014008762A (es) 2014-08-27
JP2017223710A (ja) 2017-12-21
CN106443016B (zh) 2019-08-13
CN106443016A (zh) 2017-02-22
RU2014133701A (ru) 2016-03-27
CN104105966A (zh) 2014-10-15
US20140342382A1 (en) 2014-11-20

Similar Documents

Publication Publication Date Title
BR122020002986A2 (enExample)
BR112014017815A2 (enExample)
BR112014017625A2 (enExample)
BR112014017659A2 (enExample)
BR112014017592A2 (enExample)
BR112014019495A2 (enExample)
BR112014017607A2 (enExample)
BR112014019330A2 (enExample)
BR112013027865A2 (enExample)
BR112014017609A2 (enExample)
BR112014017588A2 (enExample)
BR112014017647A2 (enExample)
BR112014013184A8 (enExample)
BR112014017623A2 (enExample)
BR112014017652A2 (enExample)
BR112014017627A2 (enExample)
BR112014019568A2 (enExample)
BR112014017621A2 (enExample)
BR112014017631A2 (enExample)
BR112014017622A2 (enExample)
BR112014017934A2 (enExample)
BR112014017921A2 (enExample)
BR112014017589A2 (enExample)
BR112014017671A2 (enExample)
BR112014017667A2 (enExample)

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2551 DE 26-11-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.